Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
32.8 HKD | +12.52% | +8.79% | -33.20% |
Apr. 12 | Keymed Biosciences Advances Solid Tumors Drug With First Patient Study | MT |
Mar. 27 | KeyMed Biosciences’ Attributable Loss Widens in 2023 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 2162 Stock
- Revisions Keymed Biosciences Inc.